The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, the OcuMet Beacon.

Neurogen Biomarking has announced a collaboration with NeuroX to support patients’ journey on its brain health care ecosystem ...

Hilo (formerly known as Aktiia), has raised $42m in an oversubscribed Series B funding round, bringing its total funding to ...

GE HealthCare is expecting its 2025 revenues to take a hit of around $500m due to the Trump administration’s imposition of ...

The US FDA has approved Element Science’s premarket approval (PMA) application for its Jewel Patch Wearable Cardioverter ...

Neuralink is currently conducting the first-in-human PRIME study (NCT06429735) in the US. Credit: Shutterstock/Kemarrravv13. The US Food and Drug Administration (FDA ...

The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...

US-based medical device technology company HemoSonics has won the Marketing award in the 2025 Medical Device Network ...

CAD and Microsoft to incorporate a suite of AI-powered mammography solutions into ProFound Breast Health Suite on the ...

A baby has been born following an AI-automated in vitro fertilisation (IVF) procedure conducted remotely by engineers and ...

When Donald Trump descended a golden escalator at Trump Tower in New York City in 2015 to announce the launch of his first ...